You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune Checkpoint Inhibitors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adjuvant Immune Checkpoint Inhibitors in Postoperative

Recruiting
  • Hepatocellular Carcinoma
  • Immune Checkpoint Inhibitors Based Adjuvant therapy
  • Nanning, Guangxi, China
    Jian-Hong Zhong
Jan 18, 2023

ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced

Completed
  • NSCLC
  • Immune checkpoint inhibitors plus angiogenesis inhibitors
  • Immune checkpoint inhibitors without angiogenesis inhibitors
  • Suzhou, Jiangsu, China
    The Affiliated Suzhou Hospital of Nanjing Medical University
Jan 17, 2023

Immune Checkpoint Inhibitors(ICPis)-Induced Endocrine

Completed
  • Immune Checkpoint Inhibitor
  • Endocrine Toxicity
    • Nanjing, Jiangsu, China
      First Affiliated Hospital, Nanjing Medical University
    Jan 6, 2023

    Immunotherapy, Immune Checkpoint Inhibitors, Immune-related Adverse Event Trial in Amiens (blood retriewal)

    Recruiting
    • Immunotherapy
    • +5 more
    • blood retriewal
    • Amiens, Picardie, France
      CHU Amiens Picardie
    Apr 3, 2023

    Myocarditis, Immune Checkpoint Inhibitors, Cardiotoxicity Trial in Adelaide (Immune Checkpoint Inhibitors)

    Recruiting
    • Myocarditis
    • +3 more
    • Immune Checkpoint Inhibitors
    • Adelaide, South Australia, Australia
      Flinders Medical Centre
    Apr 21, 2022

    Immune Checkpoint Inhibitor, Lung Cancer, Liver Biomarkers Trial in Amiens (Blood sample)

    Recruiting
    • Immune Checkpoint Inhibitor
    • +3 more
    • Blood sample
    • Amiens, France
      CHU Amiens
    Dec 8, 2022

    Myocarditis Trial (Abatacept 250 MG)

    Not yet recruiting
    • Myocarditis
    • Abatacept 250 MG
    • (no location specified)
    Jul 5, 2022

    Renal Cell Carcinoma, Bladder Cancer, MSI-H Cancer Trial in Paris (Arterial Doppler for Flow Mediated Reserve measurement)

    Recruiting
    • Renal Cell Carcinoma
    • +3 more
    • Arterial Doppler for Flow Mediated Reserve measurement
    • Paris, France
      INstitut Mutualiste Montsouris
    Aug 29, 2023

    SCLC,Extensive Stage Trial in Hangzhou (Thoracic radiotherapy)

    Recruiting
    • SCLC,Extensive Stage
    • Thoracic radiotherapy
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Sep 14, 2022

    Solid Tumor Trial in Ann Arbor (Potato starch)

    Suspended
    • Solid Tumor
    • Potato starch
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Oct 10, 2022

    Immune Checkpoint Inhibitors in Genitourinary Malignancies

    Suspended
    • Carcinoma, Renal Cell
    • Carcinoma, Urothelial
    • Immune cell and CTC detection procedures
    • Durham, North Carolina
      Duke University Medical Center
    Nov 11, 2022

    Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Nashville (Itacitinib, Corticosteroid, Endoscopic

    Not yet recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • Malignant Solid Neoplasm
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Dec 20, 2022

    Cervical Cancer, Cervical Carcinoma Trial in Guangzhou (Zimberelimab, Lenvatinib)

    Not yet recruiting
    • Cervical Cancer
    • Cervical Carcinoma
    • Guangzhou, China
      Sun Yat-sen University Cancer Cetntre
    Apr 9, 2023

    Lung Cancer Trial in Wuhan (Pirfenidone)

    Recruiting
    • Lung Cancer
    • Wuhan, Hubei, China
      Hubei Cancer Hospital
    Mar 24, 2023

    CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term

    Completed
    • Paraneoplastic Syndromes
    • This is a non-interventional study. We will collect clinical data exclusively, and will do so by reviewing all available patients clinical records.
    • Lyon, France
      Centre de référence des syndromes neurologiques paranéoplasiques
    Jul 11, 2023

    Troponin to Detect Major Cardiovasculaire Advserse Events on

    Recruiting
    • Cancer
    • +2 more
    • No intervention
    • Paris, France
      Institut Mutualiste Montsouris
    Aug 22, 2023

    Thymic Carcinoma Trial in New York (KN046)

    Recruiting
    • Thymic Carcinoma
    • New York, New York
      Weill Cornell Medicine
    Sep 20, 2022

    Endocrine Autoimmune Toxicity Due to Immune Checkpoint

    Recruiting
    • Thyroid
    • +2 more
      • New York, New York
        Mount Sinai Hospital /Tisch Cancer Cancer/Ruttenberg Treatment C
      Oct 25, 2022

      Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma

      Active, not recruiting
      • Non Small Cell Lung Cancer
      • Immune signature in serum associated to the metabolic signature
      • Meta-genomic signature of intestinal flora
      • La Tronche, Isère, France
        University Hospital, Grenoble
      Jan 6, 2023

      CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors

      Recruiting
      • Myocarditis
      • +5 more
      • Paris, France
        AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
      Aug 19, 2022

      Relapsed/Refractory Non-Hodgkin Lymphoma, Advanced Solid Tumors Trial in Beijing (Chidamide, Decitabine, Immune checkpoint

      Recruiting
      • Relapsed/Refractory Non-Hodgkin Lymphoma
      • Advanced Solid Tumors
      • Beijing, Beijing, China
        Biotherapeutic Department, Chinese PLA General Hospital
      Apr 8, 2022

      Head Neck Cancer, Lung Cancer Trial in Rouen (Vascular investigation)

      Recruiting
      • Head and Neck Cancer
      • Lung Cancer
      • Vascular investigation
      • Rouen, France
      • +1 more
      Dec 9, 2022

      Uterine Cervical Tumors, Cancer of Cervix, Cervical Cancer Trial (Cadonilimab, Nab paclitaxel)

      Not yet recruiting
      • Uterine Cervical Neoplasms
      • +5 more
      • (no location specified)
      Apr 9, 2023

      Acute Radiation Pneumonitis in Prior Receipt of Immune

      Recruiting
      • Cancer Patients
      • Cancer patients underwent thoracic intensity-modulated radiotherapy
      • Wuhan, Hubei, China
        Hubei Cancer Hospital
      Aug 4, 2022

      Immune-checkpoint Inhibitors and Surrogate Endpoints in Cancer

      Completed
      • Cancer Treated With Immune-checkpoint Inhibitors
      • Immune checkpoint inhibitor
      • Bordeaux, France
        Institut Bergonié, Comprehensive Cancer Center
      Dec 6, 2021